Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 18 di 18
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 2021 Roncato, RossanaBignucolo, AlessiaBelluco, ClaudioPucciarelli, Salvatore + FRONTIERS IN PHARMACOLOGY - -
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 2021 Poetto, AS.Roncato, R. + PHARMADVANCES - -
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 2021 Roncato R.Bignucolo A.Gagno S.Cecchin E.Toffoli G. + CANCERS - -
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer 2020 Romualdi, ChiaraRoncato, Rossana + PHARMACOGENOMICS - -
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 2020 Gagno S.Poletto E.Romualdi C.Roncato R. + GYNECOLOGIC ONCOLOGY - -
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 2019 Roncato R.Bignucolo A. + FRONTIERS IN ONCOLOGY - -
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 2019 Roncato R.Bignucolo A.Cecchin E. + GENES - -
PREEMPTIVE PHARMACOGENOMIC TESTING FOR PREVENTING ADVERSE DRUG REACTIONS (PREPARE): STATE OF ART AND PRELIMINARY RESULTS ON GENOTYPE ACTIONABILITY 2019 Alessia BignucoloSilvia MezzaliraRossana RoncatoFabio PuglisiGiuseppe Toffoli + - - PERSONALIZED MEDICINE
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients 2018 Cecchin E.Roncato R.Bignucolo A. + FRONTIERS IN PHARMACOLOGY - -
Development of an Integrated Health IT Platform for a Precision Medicine Setting 2018 Roncato, RBignucolo, AToffoli, GCecchin, E + PUBLIC HEALTH GENOMICS - -
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 2018 ECCA, FABIOBignucolo A.Roncato R.Cecchin E. + CLINICAL PHARMACOLOGY & THERAPEUTICS - -
DEVELOPMENT OF AN INTEGRATED HEALTH IT PLATFORM FOR A PRECISE AND COST-EFFECTIVE THERAPY IN ONCOLOGY 2018 Roncato, RBignucolo, AToffoli, GCecchin, E + BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - -
Innovative strategies for tailoring therapy in cancer patient pharmacogenetics and therapy personalization in metastatic colorectal cancer patients treated with irinotecan 2017 Roncato, Rossana - - -
Genetic biomarkers for hepatocellular cancer risk in a caucasian population. 2017 Cecchin EBignucolo ARoncato R + WORLD JOURNAL OF GASTROENTEROLOGY - -
Pharmacogenomics of targeted agents for personalization of colorectal cancer treatment 2017 Bignucolo A.Cecchin E.Roncato R. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Cost evaluation of irinotecan-related toxicities associated with the UGT1A1*28 patient genotype 2017 RONCATO, ROSSANAGIODINI, LUCIANA + CLINICAL PHARMACOLOGY & THERAPEUTICS - -
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine 2016 RONCATO, ROSSANA + PHARMACOGENOMICS - -
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 2015 GIODINI, LUCIANARONCATO, ROSSANAGAGNO, SARA + INTERNATIONAL JOURNAL OF CANCER - -
Mostrati risultati da 1 a 18 di 18
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile